"The directives ... provide a possible road map that health researchers say could increase the number of uninsured Americans and weaken safety net protections for low-income people.... The drug order Trump rescinded called on [CMS] to test ways to lower drug costs ... and having states try to get better prices by banding together to buy certain expensive cell and gene therapies. That might indicate Trump expects to do less on drug pricing this term or even roll back drug price negotiation in Medicare."  MORE >>